CRIS Q4 2022 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-7.9% YoY

Gross Profit

$3M97.5% margin

Operating Income

-$10M-354.0% margin

Net Income

-$11M-392.4% margin

EPS (Diluted)

$-2.35

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$109M

Total Liabilities

$62M

Stockholders' Equity

$47M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-7.9%
Gross Profit	$3M	$3M	-5.4%
Operating Income	-$10M	-$13M	+18.7%
Net Income	-$11M	-$14M	+16.8%

Revenue Segments

Gross Royalty Revenue

$3M100%

Contra Revenue

-$14,000-0%